Literature DB >> 11413163

Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction.

J E Brittain1, K J Mlinar, C S Anderson, E P Orringer, L V Parise.   

Abstract

Peripheral human red blood cells (RBCs) are not generally known to become activated and adhesive in response to cell signaling. We show, however, that soluble thrombospondin via integrin-associated protein (IAP; CD47) increases the adhesiveness of sickle RBCs (SS RBCs) by activating signal transduction in the SS RBC. This stimulated adhesion requires occupancy of IAP and shear stress and is mediated by the activation of large G proteins and tyrosine kinases. Reticulocyte-enriched RBCs derived from sickle-cell disease (SCD) patients are most responsive to IAP-induced activation. These studies therefore establish peripheral SS RBCs as signaling cells that respond to a novel synergy between IAP-induced signal transduction and shear stress, suggesting new therapeutic targets in SCD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413163      PMCID: PMC200189          DOI: 10.1172/JCI10817

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Hemodynamic shear stress and its role in atherosclerosis.

Authors:  A M Malek; S L Alper; S Izumo
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia.

Authors:  C C Joneckis; R L Ackley; E P Orringer; E A Wayner; L V Parise
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

3.  Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.

Authors:  M Sugimoto; S Tsuji; M Kuwahara; H Matsui; S Miyata; Y Fujimura; A Yoshioka
Journal:  Int J Hematol       Date:  1999-01       Impact factor: 2.490

4.  Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium.

Authors:  R A Swerlick; J R Eckman; A Kumar; M Jeitler; T M Wick
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

Review 5.  Mechanical factors affecting hemostasis and thrombosis.

Authors:  V T Turitto; C L Hall
Journal:  Thromb Res       Date:  1998-12-15       Impact factor: 3.944

6.  Changes in G protein pattern and in G protein-dependent signaling during erythropoietin- and dimethylsulfoxide-induced differentiation of murine erythroleukemia cells.

Authors:  F Kesselring; K Spicher; H Porzig
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

7.  Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.

Authors:  H A Brittain; J R Eckman; R A Swerlick; R J Howard; T M Wick
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

8.  Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells.

Authors:  K Neote; W Darbonne; J Ogez; R Horuk; T J Schall
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

9.  Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.

Authors:  A G Gao; F P Lindberg; M B Finn; S D Blystone; E J Brown; W A Frazier
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

10.  Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.

Authors:  P V Browne; D F Mosher; M H Steinberg; R P Hebbel
Journal:  Am J Hematol       Date:  1996-04       Impact factor: 10.047

View more
  25 in total

1.  Adhesively-tensed cell membranes: lysis kinetics and atomic force microscopy probing.

Authors:  Alina Hategan; Richard Law; Samuel Kahn; Dennis E Discher
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

Review 2.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

3.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

4.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

5.  Integrin-associated protein (CD47): an unusual activator of G protein signaling.

Authors:  E Brown
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

Authors:  Marilyn J Telen
Journal:  ISBT Sci Ser       Date:  2016-11-15

Review 7.  Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.

Authors:  Marcus A Carden; Ross M Fasano; Emily Riehm Meier
Journal:  Blood Rev       Date:  2019-11-05       Impact factor: 8.250

8.  Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.

Authors:  Patricia Sánchez-Rodríguez; Marina C Rodríguez; Jesús Sánchez-Yagüe
Journal:  Tumour Biol       Date:  2015-02-22

9.  Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain.

Authors:  Suhita Gayen Betal; B N Yamaja Setty
Journal:  Transl Res       Date:  2008-09-04       Impact factor: 7.012

10.  4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins.

Authors:  Kris P Jeremy; Zoe E Plummer; David J Head; Tracey E Madgett; Kelly L Sanders; Amanda Wallington; Jill R Storry; Florinda Gilsanz; Jean Delaunay; Neil D Avent
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.